Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
It's Biogen
I agree. All other studies have to be IV or sub cut and the good Dr has explained the implications of this in terms of cost and toxicity.
Can only bring great news for us when other companies see the benefit of inhaled treatment.
And this...
RE: CNNThu 23:48
Gates Foundation support Abcellera who are collaborators with Lilly on the mAb ph III study :-(
https://www.abcellera.com/news/2019-03-abcellera-signs-agreement-with-global-health-foundation
CNNThu 23:25
CNN just did a piece on a therapeutic for COVID using mAbs and namechecked Lilly. This MAY be what Gates was chatting about. Hopefully it's ours though as this one has to be via IV and as we know that has toxicity issues.https://investor.lilly.com/news-releases/news-release-details/lilly-initiates-phase-3-trial-ly-cov555-prevention-covid-19-long
I'll repost this too as it's also been lost.
Gates Foundation support Abcellera who are collaborators with Lilly on the mAb ph III study :-(
https://www.abcellera.com/news/2019-03-abcellera-signs-agreement-with-global-health-foundation
CNN just did a piece on a therapeutic for COVID using mAbs and namechecked Lilly. This MAY be what Gates was chatting about. Hopefully it's ours though as this one has to be via IV and as we know that has toxicity issues.https://investor.lilly.com/news-releases/news-release-details/lilly-initiates-phase-3-trial-ly-cov555-prevention-covid-19-long
Morning.
If you haven't used your ISA allowances this year or opened a new one could you close the Cash ISA and then just put cash into a S&S ISA?
Thank you. No wonder the alerts were going like crazy.
What's been going on? My phone sending me all sorts of alerts!!!
Price 276
I live in Scotland and we are moving at a much slower pace than other parts of the UK - and some are unhappy with that. From experience, pubs are taking names and contact numbers, gyms and pools still closed, shielding people have been given a bit of freedom today. It's a shame the UK as a whole doing things differently as mixed messages are confusing (totally apolitical statement).
Agree we need a robust testing structure from gov't.
Hope all goes well.
Best wishes.
Well that was more excitement than I was imagining today!!! Managed to buy more at prices I didn't expect to see.
I think that's right 9pm Thursday.
I've just had this emailed from Redchip...
Learn About Tiziana Life Sciences (NASDAQ: TLSA) in Exclusive Webinar and Q&A Session with CEO
Thursday, July 30 at 4:00 PM ET
Tiziana Life Sciences (NASDAQ: TLSA) is a dual-listed clinical stage company developing targeted therapeutics to transform treatment of liver diseases, inflammatory diseases, and cancer and has developed proprietary oral, nasal, and inhaled formulation technologies that could transform immunotherapies with Monoclonal Antibodies currently administered intravenously for multiple indications.
Tiziana’s clinical pipeline includes drug assets for Crohn's and hepatocellular carcinoma, and the Company’s two lead drug candidates, Foralumab and Milciclib, uniquely target the root cause of diseases with large unmet needs in multibillion-dollar markets. Tiziana is also accelerating development of anti-IL6 receptor monoclonal antibody (mAb) for treatment of COVID-19 lung inflammation.
Join Dr. Kunwar Shailubhai, CEO of Tiziana Life Sciences, for an exclusive investor webinar and live Q&A session, Thursday, July 30, 2020 at 4 PM ET to learn more.
To register for the free webinar, please visit visit this webpage: http://go.pardot.com/e/136741/corporate-webinar-register-68-/6bfw53/297016584?h=crmWu3rF9YqXNppKFO2KlNLrj53tPaykm44XIr2WRGE.
Key Highlights:
Planned spinout of genomics-based personalized medicine businessesLaunching clinical study of COVID-19 monoclonal antibodyStrong intellectual property protectionsTransformational platform technologies